196 related articles for article (PubMed ID: 31405169)
1. The Abnormal CD4+T Lymphocyte Subset Distribution and Vbeta Repertoire in New-onset Rheumatoid Arthritis Can Be Modulated by Methotrexate Treament.
Monserrat J; Bohórquez C; Gómez Lahoz AM; Movasat A; Pérez A; Ruíz L; Díaz D; Chara L; Sánchez AI; Albarrán F; Sanz I; Álvarez-Mon M
Cells; 2019 Aug; 8(8):. PubMed ID: 31405169
[TBL] [Abstract][Full Text] [Related]
2. Methrotexate Treatment Inmunomodulates Abnormal Cytokine Expression by T CD4 Lymphocytes Present in DMARD-Naïve Rheumatoid Arthritis Patients.
Monserrat Sanz J; Bohórquez C; Gómez AM; Movasat A; Pérez A; Ruíz L; Diaz D; Sánchez AI; Albarrán F; Sanz I; Álvarez-Mon M
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32961930
[TBL] [Abstract][Full Text] [Related]
3. Association of a Type 2-Polarized T Cell Phenotype With Methotrexate Nonresponse in Patients With Rheumatoid Arthritis.
Slauenwhite D; McAlpine SM; Hanly JG; Malik A; Haidl ID; Marshall JS; Issekutz TB
Arthritis Rheumatol; 2020 Jul; 72(7):1091-1102. PubMed ID: 32039570
[TBL] [Abstract][Full Text] [Related]
4. In active chronic rheumatoid arthritis, dipeptidyl peptidase IV density is increased on monocytes and CD4(+) T lymphocytes.
Ellingsen T; Hornung N; Møller BK; Hjelm-Poulsen J; Stengaard-Pedersen K
Scand J Immunol; 2007 Oct; 66(4):451-7. PubMed ID: 17850590
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of methotrexate on the increased CCR2 density on circulating CD4 T lymphocytes and monocytes in active chronic rheumatoid arthritis, with a down regulation only on monocytes in responders.
Ellingsen T; Hornung N; Møller BK; Poulsen JH; Stengaard-Pedersen K
Ann Rheum Dis; 2007 Feb; 66(2):151-7. PubMed ID: 16905577
[TBL] [Abstract][Full Text] [Related]
6. CD39 positive regulatory T cell frequency as a biomarker of treatment response to methotrexate in rheumatoid arthritis.
Gupta V; Katiyar S; Singh A; Misra R; Aggarwal A
Int J Rheum Dis; 2018 Aug; 21(8):1548-1556. PubMed ID: 30146748
[TBL] [Abstract][Full Text] [Related]
7. Rheumatoid Arthritis Patients, Both Newly Diagnosed and Methotrexate Treated, Show More DNA Methylation Differences in CD4
Guderud K; Sunde LH; Flåm ST; Mæhlen MT; Mjaavatten MD; Lillegraven S; Aga AB; Evenrød IM; Norli ES; Andreassen BK; Franzenburg S; Franke A; Haavardsholm EA; Rayner S; Gervin K; Lie BA
Front Immunol; 2020; 11():194. PubMed ID: 32117312
[No Abstract] [Full Text] [Related]
8. CD45RA-Foxp3(high) activated/effector regulatory T cells in the CCR7 + CD45RA-CD27 + CD28+central memory subset are decreased in peripheral blood from patients with rheumatoid arthritis.
Matsuki F; Saegusa J; Miyamoto Y; Misaki K; Kumagai S; Morinobu A
Biochem Biophys Res Commun; 2013 Sep; 438(4):778-83. PubMed ID: 23747721
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate Treatment of Newly Diagnosed RA Patients Is Associated With DNA Methylation Differences at Genes Relevant for Disease Pathogenesis and Pharmacological Action.
Guderud K; Sunde LH; Flåm ST; Mæhlen MT; Mjaavatten MD; Norli ES; Evenrød IM; Andreassen BK; Franzenburg S; Franke A; Rayner S; Gervin K; Lie BA
Front Immunol; 2021; 12():713611. PubMed ID: 34867944
[TBL] [Abstract][Full Text] [Related]
10. Methotrexate preferentially affects Tc1 and Tc17 subset of CD8 T lymphocytes.
Sandhu A; Ahmad S; Kaur P; Bhatnagar A; Dhawan V; Dhir V
Clin Rheumatol; 2019 Jan; 38(1):37-44. PubMed ID: 29464523
[TBL] [Abstract][Full Text] [Related]
11. The immunosuppressive effect of methotrexate in active rheumatoid arthritis patients vs. its stimulatory effect in nonactive patients, as indicated by cytometric measurements of CD4+ T cell subpopulations.
Herman S; Zurgil N; Langevitz P; Ehrenfeld M; Deutsch M
Immunol Invest; 2004 Aug; 33(3):351-62. PubMed ID: 15495793
[TBL] [Abstract][Full Text] [Related]
12. Up-regulated dipeptidyl-peptidase IV (CD26) on monocytes was unaffected by effective DMARD treatment in early steroid and DMARD-naive rheumatoid arthritis.
Ellingsen T; Hansen I; Thorsen J; Kuno Møller B; Tarp U; Jacobsen S; Lund Hetland M; Vestergaard A; Hørslev-Petersen K; Stengaard-Pedersen K
Clin Exp Rheumatol; 2012; 30(1):58-63. PubMed ID: 22273590
[TBL] [Abstract][Full Text] [Related]
13. An immunological biomarker to predict MTX response in early RA.
Ponchel F; Goëb V; Parmar R; El-Sherbiny Y; Boissinot M; El Jawhari J; Burska A; Vital EM; Harrison S; Conaghan PG; Hensor E; Emery P
Ann Rheum Dis; 2014 Nov; 73(11):2047-53. PubMed ID: 23989988
[TBL] [Abstract][Full Text] [Related]
14. Differences in IDO1
Malik AE; Slauenwhite D; McAlpine SM; Hanly JG; Marshall JS; Issekutz TB
Front Immunol; 2024; 15():1352251. PubMed ID: 38840915
[TBL] [Abstract][Full Text] [Related]
15. Influence of polysaccharide fractions isolated from Caltha palustris L. on the cellular immune response in collagen-induced arthritis (CIA) in mice. A comparison with methotrexate.
Suszko A; Obmińska-Mrukowicz B
J Ethnopharmacol; 2013 Jan; 145(1):109-17. PubMed ID: 23123796
[TBL] [Abstract][Full Text] [Related]
16. Methotrexate reduces vaccine-specific immunoglobulin levels but not numbers of circulating antibody-producing B cells in rheumatoid arthritis after vaccination with a conjugate pneumococcal vaccine.
Kapetanovic MC; Nagel J; Nordström I; Saxne T; Geborek P; Rudin A
Vaccine; 2017 Feb; 35(6):903-908. PubMed ID: 28081972
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate treatment affects effector but not regulatory T cells in juvenile idiopathic arthritis.
Bulatović Ćalasan M; Vastert SJ; Scholman RC; Verweij F; Klein M; Wulffraat NM; Prakken BJ; van Wijk F
Rheumatology (Oxford); 2015 Sep; 54(9):1724-34. PubMed ID: 25877908
[TBL] [Abstract][Full Text] [Related]
18. Influence of longterm therapy with methotrexate and low dose corticosteroids on type 1 and type 2 cytokine production in CD4+ and CD8+ T lymphocytes of patients with rheumatoid arthritis.
Schuerwegh AJ; van Offel JF; Bridts CH; Stevens WJ; De Clerck LS
J Rheumatol; 2001 Aug; 28(8):1793-9. PubMed ID: 11508581
[TBL] [Abstract][Full Text] [Related]
19. Chromosome conformation signatures define predictive markers of inadequate response to methotrexate in early rheumatoid arthritis.
Carini C; Hunter E; ; Ramadass AS; Green J; Akoulitchev A; McInnes IB; Goodyear CS
J Transl Med; 2018 Jan; 16(1):18. PubMed ID: 29378619
[TBL] [Abstract][Full Text] [Related]
20. Cell surface CD28 levels define four CD4+ T cell subsets: abnormal expression in rheumatoid arthritis.
Salazar-Fontana LI; Sanz E; Mérida I; Zea A; Sanchez-Atrio A; Villa L; Martínez-A C; de la Hera A; Alvarez-Mon M
Clin Immunol; 2001 May; 99(2):253-65. PubMed ID: 11318597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]